Lappe Mark · Chief Executive Officer at Inhibrx Biosciences, Inc. · 3h agono track record yet
Long 25,000 shares of INBX
Bought 25,000 @ $105.82 avg · $2,645,399 · 2026-09-08
Form 4: Lappe Mark bought INBX
Lappe Mark (Chief Executive Officer at Inhibrx Biosciences, Inc.) reported an open-market purchase of 25,000 shares of INBX at an average $105.82, roughly $2,645,399, in a Form 4 filed 2026-09-08.